Remove Healthcare Remove Leads Remove Pharma Remove Professional Services
article thumbnail

Medicare savings won’t make a dent in healthcare costs

World of DTC Marketing

SUMMARY: Allowing Medicare to negotiate drug prices is popular with voters because the media has been focused on the high price of some drugs, but this measure won’t lead to lower healthcare costs. The drug industry is trying to convince voters that government negotiations with drug companies will lead to less innovation.

article thumbnail

Pharma R&D productivity dips, but efficiency gains give hope

Clarivate

To learn more about how Clarivate and CMR International help pharmas future-proof their portfolios, please visit us here. Jasmin Mehta is a Senior Manager within the Life Science Professional Services team at Clarivate. The post Pharma R&D productivity dips, but efficiency gains give hope appeared first on Clarivate.

Pharma 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Engaging Patients “Just-In-Time” with Machine Learning

Impetus Digital

A: Most of the pharma companies that work with us are actually going to be more in the specialty space but I’ll use your example. The conversation would be mainly for you to understand what is the role of digital therapeutics within pharma. “What am I trying to achieve? I am trying to get my patients to be well supported.

article thumbnail

A Life Sciences case study from the heart of Europe

Clarivate

Its product portfolio covers many important therapeutic areas, including women’s healthcare, central nervous system and cardiovascular health. 53% of pharma CEOs report regulatory changes as a top disruptive trend* Gedeon Richter had a need to streamline regulatory monitoring and impact assessments.